Xiaomei Wang
Chinese Academy Of Medical Science & Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
New IMB16-4 Nanoparticles Improved Oral Bioavailability and Enhanced Anti-Hepatic Fibrosis on Rats.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 14, 2021
Costunolide Loaded in pH-Responsive Mesoporous Silica Nanoparticles for Increased Stability and an Enhanced Anti-Fibrotic Effect.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 26, 2021
Novel IMB16-4 Compound Loaded into Silica Nanoparticles Exhibits Enhanced Oral Bioavailability and Increased Anti-Liver Fibrosis In Vitro.
Journal: Molecules (Basel, Switzerland)
Published: February 09, 2021
Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis.
Journal: Annals of hepatology
Published: July 21, 2020
A Novel Diagnostic Nomogram for Noninvasive Evaluating Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection.
Journal: BioMed research international
Published: December 11, 2019
Management of Diabetes Mellitus in Patients with Chronic Liver Diseases.
Journal: Journal of diabetes research
Published: September 16, 2019
De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine.
Journal: Annals of clinical microbiology and antimicrobials
Published: November 05, 2015
Identification and clinical significance of an elevated level of serum aminoacylase-1 autoantibody in patients with hepatitis B virus-related liver cirrhosis.
Journal: Molecular medicine reports
Published: August 02, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026